Published in Lancet on December 08, 1990
Chemotherapy for pancreatic carcinoma. Lancet (1991) 0.75
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 2.53
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy. J Infect Dis (2001) 2.50
Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer. Ann Oncol (2014) 2.29
Yoga and chemoreflex response to hypoxia and hypercapnia. Lancet (2000) 1.77
Identification of a Fab interaction footprint site on an icosahedral virus by cryoelectron microscopy and X-ray crystallography. Nature (1992) 1.71
Disseminated human herpesvirus 6 infection in AIDS. Lancet (1993) 1.64
Cardiovascular, cerebrovascular, and respiratory changes induced by different types of music in musicians and non-musicians: the importance of silence. Heart (2005) 1.58
Incidence of hepatitis delta virus infection in acute HBsAg-negative hepatitis. J Infect Dis (1989) 1.48
High prevalence of human T cell lymphotropic virus type II infection in patients affected by human immunodeficiency virus type 1--associated predominantly sensory polyneuropathy. J Infect Dis (1995) 1.47
Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression. Br J Pharmacol (2009) 1.45
Granulocyte dysplasia and dysfunction, and CD11/CD18 defects in myelodysplastic syndromes. Leuk Lymphoma (1996) 1.42
Thrombotic thrombocytopenic purpura treatment in year 2000. Haematologica (2000) 1.42
When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study. AIDS (2001) 1.41
Rebuttal to: The usefulness of compression ultrasonography of the lower limbs in patients with a clinical suspicion of pulmonary embolism. Thromb Haemost (2001) 1.39
Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy. Neurology (2000) 1.39
Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS (1999) 1.36
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res (1998) 1.36
Slow breathing reduces chemoreflex response to hypoxia and hypercapnia, and increases baroreflex sensitivity. J Hypertens (2001) 1.34
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS (1997) 1.32
Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains. Antimicrob Agents Chemother (1986) 1.31
HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet (1986) 1.31
Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Defic Syndr (2001) 1.31
SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc Natl Acad Sci U S A (2001) 1.29
Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome. J Infect Dis (1985) 1.29
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study. Eur J Cancer (2011) 1.29
Inguino-scrotal hernia of a double district ureter: case report and literature review. Hernia (2005) 1.28
Plant-derived vaccine protects target animals against a viral disease. Nat Biotechnol (1997) 1.27
Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin Exp Immunol (1985) 1.24
Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood (1996) 1.23
AIDS-defining diseases in 250 HIV-infected patients; a comparative study of clinical and autopsy diagnoses. AIDS (1992) 1.20
Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. J Clin Microbiol (2001) 1.18
Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors. Antimicrob Agents Chemother (2000) 1.17
Pseudomonas infections in patients with AIDS and AIDS-related complex. J Intern Med (1992) 1.16
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals. Antivir Ther (2000) 1.16
Malignant peritoneal mesothelioma: a multicenter study on 81 cases. Ann Oncol (2009) 1.14
Cowpea mosaic virus: from the presentation of antigenic peptides to the display of active biomaterials. Intervirology (2002) 1.12
[Contribution of immunofluorescence tests to the biological diagnosis of hydatidosis]. G Mal Infett Parassit (1966) 1.08
Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial. Br J Cancer (2011) 1.08
Echocardiography detects myocardial damage in AIDS: prospective study in 102 patients. Eur Heart J (1988) 1.08
Focal lymphocytic myocarditis in acquired immunodeficiency syndrome (AIDS): a correlative morphologic and clinical study in 26 consecutive fatal cases. J Am Coll Cardiol (1988) 1.07
Prospective study of epidemic delta infection in drug addicts. Prog Clin Biol Res (1983) 1.07
Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood (2001) 1.05
Scrotal angiokeratoma (Fordyce): histopathological and ultrastructural findings. Histol Histopathol (1992) 1.05
Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood (1997) 1.04
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis. Ann Oncol (2012) 1.03
Modulatory effects of respiration. Auton Neurosci (2001) 1.03
Structure-based design of peptide presentation on a viral surface: the crystal structure of a plant/animal virus chimera at 2.8 A resolution. Fold Des (1996) 1.02
Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science (1997) 0.99
Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus. AIDS Res Hum Retroviruses (1995) 0.98
Engineering cowpea mosaic virus RNA-2 into a vector to express heterologous proteins in plants. Virology (2000) 0.98
Influence of three-dimensional structure on the immunogenicity of a peptide expressed on the surface of a plant virus. J Mol Recognit (2000) 0.98
Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection. AIDS Res Hum Retroviruses (1996) 0.97
Disseminated Rhodococcus equi infection initially presenting as foot mycetoma in an HIV-positive patient. AIDS (1992) 0.97
Selective transport of microparticles across Peyer's patch follicle-associated M cells from mice and rats. Exp Physiol (1995) 0.96
Cryptococcus neoformans infection in a cohort of Italian AIDS patients: natural history, early prognostic parameters, and autopsy findings. Eur J Clin Microbiol Infect Dis (2001) 0.96
Clinical features of sporadic non-A, non-B hepatitis possibly associated with faecal-oral spread. Lancet (1985) 0.95
Inosiplex in recurrent herpes simplex infections. Lancet (1982) 0.95
A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients. J Neurol (1997) 0.94
Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS. AIDS (1997) 0.94
Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group. JAMA (1992) 0.93
CD4 cell counts at the third month of HAART may predict clinical failure. AIDS (1999) 0.93
HIV-1 infection, tuberculosis, and syphilis in male transsexual prostitutes in Milan, Italy. J Acquir Immune Defic Syndr (1991) 0.93
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART. J Acquir Immune Defic Syndr (2001) 0.92
Thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Italian Cooperative Group for TTP. J Rheumatol (1993) 0.92
IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy. Br Med J (Clin Res Ed) (1985) 0.92
The antioxidant activity of chondroitin-4-sulphate, in carbon tetrachloride-induced acute hepatitis in mice, involves NF-kappaB and caspase activation. Br J Pharmacol (2008) 0.92
Cardiorespiratory interactions to external stimuli. Arch Ital Biol (2005) 0.91
Simultaneously acquired hepatitis B and hepatitis D virus infections. Br Med J (Clin Res Ed) (1985) 0.91
Prolonged course and relapses of acute type A hepatitis. Boll Ist Sieroter Milan (1984) 0.91
Somatic mutation of EGFR catalytic domain and treatment with gefitinib in colorectal cancer. Ann Oncol (2005) 0.90
Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection. AIDS (1996) 0.90
Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine. J Acquir Immune Defic Syndr (1999) 0.90
Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature. Eur J Epidemiol (1998) 0.89
Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-alpha. J Biol Chem (1999) 0.89
High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication. J Infect Dis (1997) 0.89
Sarcoidosis following beta-interferon therapy for multiple myeloma. Sarcoidosis (1995) 0.89
In vitro antioxidant properties of amifostine (WR-2721, Ethyol). Cancer Chemother Pharmacol (2000) 0.89
An atypical form of alphaB-crystallin is present in high concentration in some human cataractous lenses. Identification and characterization of aberrant N- and C-terminal processing. J Biol Chem (1999) 0.88
Eosinophils and C4 predict clinical failure of combination immunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients. Haematologica (2000) 0.88
Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis. Ann Oncol (2006) 0.87
Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab (1992) 0.87
Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure. Hum Reprod (2002) 0.87
Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial. Antivir Ther (1997) 0.87
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group. Antimicrob Agents Chemother (2000) 0.87
Co-Release of GABA Does Not Occur at Glycinergic Synapses onto Lumbar Motoneurons in Juvenile Mice. Front Cell Neurosci (2012) 0.87
Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis. Br J Cancer (2012) 0.87
Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study Group. J Acquir Immune Defic Syndr (2000) 0.87
The syndrome of acquired glucocorticoid resistance in HIV infection. Baillieres Clin Endocrinol Metab (1994) 0.87
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP. Haematologica (1997) 0.87
Metachronous occurrence of seminoma and Hodgkin's lymphoma in the same patient with late-onset colon cancer. J Intern Med (1994) 0.87
Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study. Am J Gastroenterol (1994) 0.87